跳至主要内容
临床试验/JPRN-UMIN000006821
JPRN-UMIN000006821已完成4 期

Comparison of effects of aliskiren-based combination therapy between CCB and ARB in hypertensive patients with chronic kidney disease - Comparison of effects of aliskiren-based combination therapy between CCB and ARB in hypertensive patients with chronic kidney disease

Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2011年12月2日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) CKD stage 5 or on dialysis therapy 2) History of hypersensitivity to aliskiren, amlodipine, or valsartan. 3) Pregnant or suspicious women. 4) Treatment with itraconazole, cyclosporine. 5) Judged as inappropriate for the study

研究者

发起方
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine

相似试验

Comparison of effects of aliskiren-based combination... | 临床试验